Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

O Dietze

Showing results (71-80 of 78) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 78 results.
Pathology, Research and Practice|December 1, 1994
Stereologic parameters of nuclear ultrastructure as markers of the steroid receptor status in breast cancer epitheliumD Savjak, B Pikula, W H Muss, et al.
British Journal of Haematology|May 1, 1993
Long-term follow-up of patients with hairy cell leukaemia treated with pentostatin: lymphocyte subpopulations and residual bone marrow infiltrationJ Thaler, K Grünewald, C Gattringer, et al.
Leukemia Research|January 1, 1989
Immunohistological assessment of bone marrow biopsies from patients with hairy cell leukemia: changes following treatment with alpha-2-interferon and deoxycoformycinJ Thaler, H Denz, O Dietze, et al.
Regulatory Peptides|February 14, 1995
Helospectin and pituitary adenylate cyclase activating polypeptide in the human vaginaA H Graf, A Schiechl, G W Hacker, et al.
British Journal of Cancer|April 14, 2015
The genomic expression test EndoPredict is a prognostic tool for identifying risk of local recurrence in postmenopausal endocrine receptor-positive, her2neu-negative breast cancer patients randomised within the prospective ABCSG 8 trialF Fitzal, M Filipits, M Rudas, et al.
Gynakologisch-Geburtshilfliche Rundschau|March 22, 2003
[Sentinel lymph node biopsy in breast cancer patients--results and experience after 500 sentinel lymph node biopsies]R Reitsamer, C Menzel, F Peintinger, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 5, 2012
EndoPredict improves the prognostic classification derived from common clinical guidelines in ER-positive, HER2-negative early breast cancerP Dubsky, M Filipits, R Jakesz, et al.
British Journal of Cancer|October 26, 2013
The EndoPredict score provides prognostic information on late distant metastases in ER+/HER2- breast cancer patientsP Dubsky, J C Brase, R Jakesz, et al.
Pageof 8

Showing results (71-80 of 78) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 78 results.
Pathology, Research and Practice|December 1, 1994
Stereologic parameters of nuclear ultrastructure as markers of the steroid receptor status in breast cancer epitheliumD Savjak, B Pikula, W H Muss, et al.
British Journal of Haematology|May 1, 1993
Long-term follow-up of patients with hairy cell leukaemia treated with pentostatin: lymphocyte subpopulations and residual bone marrow infiltrationJ Thaler, K Grünewald, C Gattringer, et al.
Leukemia Research|January 1, 1989
Immunohistological assessment of bone marrow biopsies from patients with hairy cell leukemia: changes following treatment with alpha-2-interferon and deoxycoformycinJ Thaler, H Denz, O Dietze, et al.
Regulatory Peptides|February 14, 1995
Helospectin and pituitary adenylate cyclase activating polypeptide in the human vaginaA H Graf, A Schiechl, G W Hacker, et al.
British Journal of Cancer|April 14, 2015
The genomic expression test EndoPredict is a prognostic tool for identifying risk of local recurrence in postmenopausal endocrine receptor-positive, her2neu-negative breast cancer patients randomised within the prospective ABCSG 8 trialF Fitzal, M Filipits, M Rudas, et al.
Gynakologisch-Geburtshilfliche Rundschau|March 22, 2003
[Sentinel lymph node biopsy in breast cancer patients--results and experience after 500 sentinel lymph node biopsies]R Reitsamer, C Menzel, F Peintinger, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 5, 2012
EndoPredict improves the prognostic classification derived from common clinical guidelines in ER-positive, HER2-negative early breast cancerP Dubsky, M Filipits, R Jakesz, et al.
British Journal of Cancer|October 26, 2013
The EndoPredict score provides prognostic information on late distant metastases in ER+/HER2- breast cancer patientsP Dubsky, J C Brase, R Jakesz, et al.
Pageof 8